SIB-IMRT
Sponsors
Chinese Academy of Medical Sciences, Jing Jin, M.D., Yong Zhang,MD
Conditions
ChemoradiationChemoradiotherapyChemotherapyEsophageal NeoplasmsEsophagogastric Junction CancerEsophagus CancerGastric CancerIMRT With or Without Concurrent Chemotherapy for Esophageal Cancer
Phase 2
A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma
CompletedNCT02301481
Start: 2014-01-31End: 2017-12-31Updated: 2019-10-16
Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01
CompletedNCT02979691
Start: 2016-10-31End: 2020-04-30Target: 350Updated: 2020-07-21
A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer
NCT04062058
Start: 2019-11-20End: 2023-09-21Target: 82Updated: 2022-01-24
Phase 3
The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT
NCT01817023
Start: 2013-04-30End: 2021-03-30Target: 590Updated: 2021-01-29
Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02
NCT03308552
Start: 2017-12-01End: 2021-08-30Target: 164Updated: 2019-01-02
Radiotherapy With or Without Concurrent Chemotherapy for Extensive Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-03
NCT03328234
Start: 2017-09-01End: 2022-12-31Target: 2Updated: 2019-01-02
Simultaneous Integrated Boost vs. Routine IMRT in Limited-stage Small-cell Lung Cancer
NCT04500145
Start: 2017-07-20End: 2021-10-20Target: 350Updated: 2021-02-01
Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer
RecruitingNCT06017583
Start: 2023-09-01End: 2026-08-31Target: 48Updated: 2023-10-11